Friday, December 5, 2008 - 4:20AM EST

Review Articles

31. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases.

Author
Fernando HC;
Institution
Department of Cardiothoracic Surgery, Boston Medical Center, Boston University, Boston, Massachusetts 02118, USA. hiran.Fernando@bmc.org
Journal
Ann Thorac Surg. 2008 Feb;85(2):S780-4.
Abstract URL
Click here to view abstract

32. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.

Author
Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G;
Institution
H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA. tanvett@moffitt.org
Journal
J Thorac Oncol. 2007 Dec;2(12):1091-7.
Abstract URL
Click here to view abstract

33. Inhibition of angiogenesis in the treatment of non-small cell lung cancer.

Author
Keedy VL; Sandler AB;
Institution
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Department of Medicine, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN 37272-6307, USA. vicki.keedy@vanderbilt.edu
Journal
Cancer Sci. 2007 Dec;98(12):1825-30. Epub 2007 Sep 24.
Abstract URL
Click here to view abstract

34. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.

Author
Ung YC; Maziak DE; Vanderveen JA; Smith CA; Gulenchyn K; Lacchetti C; Evans WK;
Institution
Odette Cancer Centre and University of Toronto, Toronto, ON, Canada.
Journal
J Natl Cancer Inst. 2007 Dec 5;99(23):1753-67. Epub 2007 Nov 27.
Abstract URL
Click here to view abstract

35. Cetuximab in non-small cell lung cancer.

Author
Ademuyiwa FO; Hanna N;
Institution
Indiana University School of Medicine, Division of Hematology/Oncology, 535 Barnhill Drive, RT 473, Indianapolis, IN 46202, USA. fademuyi@iupui.edu
Journal
Expert Opin Biol Ther. 2008 Jan;8(1):107-13.
Abstract URL
Click here to view abstract

36. Setting the stage for tailored chemotherapy in the management of non-small cell lung cancer.

Author
Simon GR; Begum M; Bepler G;
Institution
Thoracic Oncology Program, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MRC-4W, Tampa, FL 33612, USA. george.simon@moffitt.org
Journal
Future Oncol. 2008 Feb;4(1):51-9.
Abstract URL
Click here to view abstract

37. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer.

Author
Jatoi A; Aranguren D;
Institution
Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Journal
J Thorac Oncol. 2007 Jan;2(1):83-90.
Abstract URL
Click here to view abstract

38. Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?

Author
Rusch VW; Tsuchiya R; Tsuboi M; Pass HI; Grunenwald D; Goldstraw P;
Institution
Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. ruschv@mskcc.org
Journal
J Thorac Oncol. 2006 Nov;1(9 Suppl):S27-31.
Abstract URL
Click here to view abstract

39. A review of vaccine clinical trials for non-small cell lung cancer.

Author
Nemunaitis J; Nemunaitis J; Nemunaitis J; Nemunaitis J;
Institution
Mary Crowley Medical Research Center, 60th Floor, 1717 Main St, Dallas, Texas 75201, USA. jnemunaitis@mcmrc.com
Journal
Expert Opin Biol Ther. 2007 Jan;7(1):89-102.
Abstract URL
Click here to view abstract

40. Antiangiogenic therapy in nonsmall cell lung cancer.

Author
Gutierrez M; Giaccone G;
Institution
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Journal
Curr Opin Oncol. 2008 Mar;20(2):176-82.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9